Related Experiment Video
Updated: Jul 31, 2025

CRISPR Gene Editing Tool for MicroRNA Cluster Network Analysis
Published on: April 25, 2022
An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus
Albertas Navickas1,2,3,4,5, Hosseinali Asgharian1,2,3,4, Juliane Winkler6
1Department of Biochemistry and Biophysics, University of California, San Francisco, CA, USA.
Abstract:
Cancer cells often co-opt post-transcriptional regulatory mechanisms to achieve pathologic expression of gene networks that drive metastasis. Translational control is a major regulatory hub in oncogenesis; however, its effects on cancer progression remain poorly understood. Here, to address this, we used ribosome profiling to compare genome-wide translation efficiencies of poorly and highly metastatic breast cancer cells and patient-derived xenografts. We developed dedicated regression-based methods to analyse ribosome profiling and alternative polyadenylation data, and identified heterogeneous nuclear ribonucleoprotein C (HNRNPC) as a translational controller of a specific mRNA regulon. We found that HNRNPC is downregulated in highly metastatic cells, which causes HNRNPC-bound mRNAs to undergo 3' untranslated region lengthening and, subsequently, translational repression. We showed that modulating HNRNPC expression impacts the metastatic capacity of breast cancer cells in xenograft mouse models. In addition, the reduced expression of HNRNPC and its regulon is associated with the worse prognosis in breast cancer patient cohorts.
Insights
Heterogeneous nuclear ribonucleoprotein C (HNRNPC) controls cancer cell metastasis by regulating gene translation. Downregulation of HNRNPC in metastatic cells leads to poorer breast cancer prognosis.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer cells utilize post-transcriptional regulation for metastasis.
- Translational control's role in cancer progression is not fully understood.
Purpose of the Study:
- To investigate translational control mechanisms in breast cancer metastasis.
- To identify key regulators of metastatic gene expression.
Main Methods:
- Ribosome profiling to compare translation efficiencies in cells with varying metastatic potential.
- Development of regression-based methods for analyzing ribosome profiling and alternative polyadenylation data.
- Xenograft mouse models to assess the impact of HNRNPC modulation on metastasis.
Main Results:
- Identified heterogeneous nuclear ribonucleoprotein C (HNRNPC) as a translational controller.
- HNRNPC downregulation in highly metastatic cells leads to 3' UTR lengthening and translational repression of target mRNAs.
- Modulating HNRNPC expression affects breast cancer cell metastatic capacity in vivo.
- Reduced HNRNPC expression correlates with worse prognosis in breast cancer patients.
Conclusions:
- HNRNPC is a critical regulator of mRNA translation impacting breast cancer metastasis.
- The HNRNPC-mediated translational control pathway is a potential therapeutic target.
- HNRNPC downregulation serves as a biomarker for poor prognosis in breast cancer.
More Related Videos
Related Concept Videos
MicroRNAs
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Regulation of Expression at Multiple Steps
Translational Regulation
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nuclear Export of mRNA

